Hypoglycemic Effet Of Some Fluoroquinolones On Normal And Diabetic Experimental Animals | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 9, Volume 28, Issue 1, July 2007, Pages 404-417 PDF (383.17 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2007.17670 | ||
| Authors | ||
| Amr Heshmat Rostom1; Ali Ibrahim Al-Sultan2 | ||
| 1Department Pharmacology College of Medicine, Al Hasa, King Faisal University. | ||
| 2Department Internal Medicine. College of Medicine, Al Hasa, King Faisal University. | ||
| Abstract | ||
| Background:Fluoroquinolones are among the anti-microbial that have widespread use for treatment of community- and hospital-acquired infections. Although uncommon, hypoglycemia has been reported with some fluoroquinolones and appears to occur most frequently in elderly patients with type 2 diabetes mellitus who were receiving therapy with oral hypoglycemics. The clinical data emerged suggest that the fluoroquinolones can affect glucose homeostasis through an unknown mechanism. The present work aimed to explore the potential effects of some fluoroquinolones on glucose metabolism and blood glucose level in experimental animals. Two fluoroquinolones (gatifloxacin, moxifloxacin) were used in the present study using different rabbit groups; normal and experimentally diabetic. Dug interaction with anti-diabetic drugs was also investigated. Safety considerations were our goal. Materials And Method: In the present work, alloxan (100 mg / kg body weight 3 successive doses, intraperitonially) was used to induce diabetes in experimental animals. The blood glucose level after alloxan was measured. Oral anti-diabetics glimepiride, rosiglitazone, and metformin produced significant lowering effect on blood glucose level in normal and diabetic animals. Gatifloxacin and moxifloxacin were similar in producing lowering of blood glucose level in non diabetic and diabetic animals and significantly potentiated the hypoglycemic action of oral anti-diabetics in the alloxan diabetic rabbits. | ||
| Keywords | ||
| Oral anti-diabetics Glimepiride; Rosiglitazone; Metformin; Fluoroquinolones (Gatifloxacin and Moxifloxacin) Alloxan and diabetes mellitus | ||
|
Statistics Article View: 206 PDF Download: 512 |
||
